Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Long Term Immunogenicity of Japanese Encephalitis Live Attenuated SA-14-14-2 Vaccine in Previously Vaccinated Bangladeshi Children and Antibody Response and Safety to a Booster Dose

NCT02514746 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02514746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02514746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Long Term Immunogenicity of Japanese Encephalitis Live Attenuated SA-14-14-2 Vaccine in Previously Vaccinated Bangladeshi Children and Antibody Response and Safety to a Booster Dose
Lead sponsor
PATH
Phase
Phase 4
Overall status
Completed
Start date
July 30, 2015
Completion date
January 12, 2017
Enrollment
561 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, japanese